MLEC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $4.75
P/E -0.4
EPS $-17.25
Revenue $6M
ROE 344.2%
52W Range $0–$23

MLEC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 2
Ex-date Split Type
Jan. 5, 2026 1-for-15 Reverse
May 14, 2025 1-for-10 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$6M
2023-06-30 → 2024-06-30
EPS$-17.25
2022-06-30 → 2025-06-30
Free Cash Flow$-2M
2023-06-30 → 2025-06-30
Net margin·
2023-06-30 → 2024-06-30
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend MLEC 5Y avg Peer Median Verdict
P/E -0.45Y avg ≈0.6 ≈0.6 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 15.4%
PeriodReportEPS ActualEPS EstSurprise
Dec. 31, 2024 $-9.00 $-9.18 2.0%
Sept. 30, 2024 $-7.50 $-10.71 30.0%
June 30, 2024 $-10.50 $-9.18 -14.4%
March 31, 2024 $-6.00 $-10.71 44.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 13
Metric Trend 202520242023
Revenue ·$6M$905.0K
Cost of Revenue $203M$279M$235M
R&D Expense $15M$17M$16M
SG&A Expense $126M$126M$117M
Operating Income $-104M$19M$98M
Interest Expense ·$41.1K$160.0K
Pretax Income $-170M$-28M$51M
Income Tax $7M$1M$-2M
Net Income $-111M$-33M$40M
EPS (Basic) $-17.25$-5.61$8.80
EPS (Diluted) $-17.25$-5.61$8.80
Shares (Diluted) ·37,870,35134,466,258
EBITDA $-104M$-9M$-7M
Balance Sheet 13
Metric Trend 202520242023
Cash & Equivalents $767.9K$27M$2.4K
Receivables ·$1M$1M
Inventory $2M$126M$465.7K
Current Assets $31M$438M$5M
PP&E (Net) $3M$75M$1M
Goodwill ·$112M$251.4K
Intangibles $75M$177M$175M
Total Assets $205M$950M$24M
Accounts Payable $7M$169M$7M
Current Liabilities $236M$427M$13M
Total Liabilities $288M$700M$14M
Retained Earnings $-110M$1M$-59M
Stockholders' Equity $-66M$1M$10M
Cash Flow 8
Metric Trend 202520242023
D&A ··$23.4K
Other Non-cash ··$44M
Operating Cash Flow $4M$40M$-41M
CapEx $6M$10M$11M
Investing Cash Flow $-36M$-27M$-26M
Financing Cash Flow $-15M$-1M$76M
Free Cash Flow $-2M$-9M$-8M
Levered FCF ·$-10M$-8M
Profitability 7
Metric Trend 202520242023
Operating Margin ·-160.8%-735.2%
Net Margin ·-130.0%-5722.2%
Pretax Margin ·-148.6%-5748.1%
EBITDA Margin ·-160.8%-732.6%
ROA -19.3%-24.9%-348.2%
ROE 344.2%-86.4%-884.5%
ROIC 164.0%-116.1%-65.5%
Liquidity & Solvency 3
Metric Trend 202520242023
Current Ratio 0.11.70.4
Quick Ratio 0.00.10.1
Interest Coverage ·-219.9-41.6
Efficiency 3
Metric Trend 202520242023
Asset Turnover ·0.20.1
Inventory Turnover 3.21.54.5
Receivables Turnover ·4.81.4
Per Share 3
Metric Trend 202520242023
Revenue / Share ·$0.15$0.03
Cash Flow / Share ·$-0.25$-0.22
EPS (TTM) $-17.25$-5.61$8.80
Valuation (TTM) 4
Metric Trend 202520242023
Revenue TTM ·$6M$905.0K
Net Income TTM $-111M$-33M$40M
P/E -0.4-2.04.2
Earnings Yield -273.8%-51.0%23.9%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-06-302024-06-302023-06-302022-06-30
Revenue · $6M $905.0K ·
Operating Margin % · -160.8% -735.2% ·
Net Income $-111M $-33M $40M $-5M
Diluted EPS $-17.25 $-5.61 $8.80 $-0.15

Institutional owners (13F) 3 filers · $4K total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 3
Value held $4K
New positions 1
Exited positions 1
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
1 (-1 vs prior Q) 1 (-1 vs prior Q) 1 (+1 vs prior Q) 0 (-1 vs prior Q) -16K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
UBS Group AG $3,511 470 97.72% Shares
Caitong International Asset Management Co., Ltd $75 10 2.09% Shares
SBI Securities Co., Ltd. $7 1 0.19% Shares

Activists & 5%+ owners 5 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Agriculture Investment Group Corp. April 7, 2026 65.10% Initial filing · SEC
Union Group Ventures Limited, Union Group International Holdings Limited, Arvesa Corp, Juan Jose Sartori Pineyro ×2 filings Feb. 25, 2025 37.80% Amendment · SEC
The Biotech Company LLC, Gastón Paladini April 17, 2024 · Initial filing Passive investment SEC
THEO I SCSp, Bioceres Group PLC April 10, 2024 · Initial filing · SEC
BG Farming Technologies Limited, THEO I SCSp, Bioceres Group PLC Jan. 9, 2023 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

MLEC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 7 analysts BUY
2 28.6% Strong Buy
4 57.1% Buy
1 14.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 20-F filed Dec 29, 2025